Philip McGuire Selected Research

Philip McGuire Research Topics

Disease

119	Psychotic Disorders (Schizoaffective Disorder) 12/2022 - 02/2007
40	Schizophrenia (Dementia Praecox) 04/2022 - 02/2008
5	Treatment-Resistant Schizophrenia 01/2022 - 12/2012
4	Mania (Manias) 01/2020 - 12/2015
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 09/2013
4	Mental Disorders (Mental Disorder) 12/2019 - 06/2005
4	Prodromal Symptoms 01/2018 - 10/2010
3	Anhedonia 11/2021 - 07/2014
3	Depressive Disorder (Melancholia) 11/2021 - 04/2011
3	Cognitive Dysfunction 01/2019 - 11/2013
3	Hallucinations (Hallucination) 12/2018 - 07/2013
2	Cerebral Cortical Thinning 01/2022 - 11/2013
1	Chronic Disease (Chronic Diseases) 02/2022
1	Neutropenia 01/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Vitamin D Deficiency 12/2021
1	Stroke (Strokes) 11/2021
1	Neurobehavioral Manifestations 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Agranulocytosis (Granulocytopenia) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Epilepsy (Aura) 10/2020
1	Sleepiness 10/2020
1	Pneumonia (Pneumonitis) 10/2020
1	Spontaneous Abortion (Miscarriage) 01/2020
1	Premature Birth (Birth, Premature) 12/2019
1	Autism Spectrum Disorder 12/2019
1	Inflammation (Inflammations) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Craniocerebral Trauma (Head Injury) 10/2018
1	Mood Disorders (Mood Disorder) 12/2017
1	Anxiety Disorders (Anxiety Disorder) 11/2017

Drug/Important Bio-Agent (IBA)

35	Antipsychotic Agents (Antipsychotics)IBA 05/2022 - 06/2010
33	Polytetrafluoroethylene (Teflon)FDA Link 12/2022 - 10/2012
20	Glutamic Acid (Glutamate)FDA Link 01/2021 - 02/2008
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
17	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 02/2008
10	Clozapine (Clozaril)FDA LinkGeneric 01/2022 - 12/2012
6	CannabidiolIBA 05/2022 - 01/2018
6	Pharmaceutical PreparationsIBA 09/2020 - 02/2008
6	Protons (Proton)IBA 08/2019 - 10/2010
5	Biological ProductsIBA 01/2022 - 10/2015
5	Oxytocin (Pitocin)FDA LinkGeneric 01/2020 - 01/2015
5	Dihydroxyphenylalanine (Dopa)IBA 12/2017 - 10/2010
4	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2022 - 09/2014
4	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 05/2011
4	Antidepressive Agents (Antidepressants)IBA 12/2019 - 11/2007
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 11/2017
3	Amisulpride (Solian)IBA 01/2021 - 10/2018
3	AntibodiesIBA 01/2021 - 01/2019
3	AutoantibodiesIBA 01/2021 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
3	gamma-Aminobutyric Acid (GABA)IBA 12/2018 - 01/2018
2	CannabinoidsIBA 05/2022 - 01/2017
2	Vitamin D FDA LinkGeneric 12/2021 - 01/2020
2	AntigensIBA 01/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2021 - 02/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 11/2020 - 02/2008
2	Acetylcysteine (Siran)FDA LinkGeneric 02/2020 - 10/2018
2	Alanine (L-Alanine)FDA Link 01/2019 - 12/2017
2	Therapeutic UsesIBA 11/2018 - 05/2015
2	Dronabinol (THC)FDA LinkGeneric 01/2017 - 04/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015 - 10/2014
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 09/2013 - 11/2009
2	3' Untranslated Regions (3' UTR)IBA 11/2009 - 08/2009
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 05/2022
1	EndocannabinoidsIBA 05/2022
1	cariprazineIBA 04/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 11/2021
1	BI 409306IBA 10/2021
1	erucylphosphocholineIBA 05/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	LipidsIBA 01/2021
1	BenzodiazepinesIBA 11/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2020
1	Clobazam (HR 376)IBA 10/2020
1	Cholecalciferol (Vitamin D3)FDA Link 01/2020
1	boldenone undecylenate (Equipoise)IBA 01/2020
1	LithiumIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	NeuropeptidesIBA 01/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019
1	CytokinesIBA 01/2019
1	CreatineIBA 01/2019
1	Inositol (Myoinositol)IBA 01/2019
1	AutoantigensIBA 01/2019
1	Olanzapine (Zyprexa)FDA Link 10/2018
1	A 7 (A-7)IBA 01/2018
1	Nicotine FDA Link 01/2018
1	Immunoglobulin IsotypesIBA 11/2017

Therapy/Procedure

5	Therapeutics 09/2020 - 12/2015
2	Contraindications 12/2021 - 10/2018
2	Secondary Prevention 01/2021 - 02/2007
2	Oral Administration 02/2020 - 10/2018
1	Immunotherapy 01/2019
1	Neurofeedback 12/2018
1	Aftercare (After-Treatment) 01/2018
1	Self Medication 01/2018